Business · 24/06/2026

FDA Releases Revised Draft Guidance for Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products

The Food and Drug Administration (FDA) has released a revised draft guidance for the pharmaceutical industry, titled "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products," in response to public comments and changes in drug development. The guidance aims to provide a more efficient and rigorous approach to generating scientific evidence for drug effectiveness.